scispace - formally typeset
K

Koji Kato

Researcher at Kyushu University

Publications -  416
Citations -  8924

Koji Kato is an academic researcher from Kyushu University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 44, co-authored 363 publications receiving 7392 citations. Previous affiliations of Koji Kato include Children's Medical Center of Dallas & University of Michigan.

Papers
More filters
Journal ArticleDOI

Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay

TL;DR: The results indicate that the real-time PCR assay is useful for diagnosing symptomatic EBV infection and for monitoring the virus load.
Journal ArticleDOI

Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

TL;DR: JSHCT played a central role in developing the “Transplant Registry Unified Management Program (TRUMP)” to enable transplantation institutes to manage patient information with emphases on convenience to institutes, safety of patient information, and quality of data management.
Journal ArticleDOI

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.

TL;DR: Results indicate that expression of GATA-1 with a defective N-terminal activation domain contributes to the expansion of TMD blast cells and that other genetic changes contribute to the development of AMKL in Down syndrome.
Journal ArticleDOI

Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia

TL;DR: FLT3/ITD was observed in 11% of childhood AML and identified to be associated with poor prognosis and a large prospective study with uniform treatment is necessary to confirm the results.
Journal ArticleDOI

Human Herpesvirus 6 Viremia in Bone Marrow Transplant Recipients: Clinical Features and Risk Factors

TL;DR: Human herpesvirus 6 (HHV-6) infection was studied in 82 bone marrow transplant (BMT) recipients and it was demonstrated that leukemia or lymphoma is an independent risk factor for HHV- 6 viremia.